48 related articles for article (PubMed ID: 26637913)
1. Biomarker Analysis in a Phase II Study of Sunitinib in Patients with Advanced Melanoma.
Decoster L; Vande Broek I; Neyns B; Majois F; Baurain JF; Rottey S; Rorive A; Anckaert E; De Mey J; De Brakeleer S; De Grève J
Anticancer Res; 2015 Dec; 35(12):6893-9. PubMed ID: 26637913
[TBL] [Abstract][Full Text] [Related]
2. A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocellular cancer.
Zhu AX; Finn RS; Mulcahy M; Gurtler J; Sun W; Schwartz JD; Dalal RP; Joshi A; Hozak RR; Xu Y; Ancukiewicz M; Jain RK; Nugent FW; Duda DG; Stuart K
Clin Cancer Res; 2013 Dec; 19(23):6614-23. PubMed ID: 24088738
[TBL] [Abstract][Full Text] [Related]
3. Results from Polish Spondyloarthritis Initiative registry (PolSPI) - methodology and data from - the first year of observation.
Guła Z; Barczyńska T; Brzosko M; Gąsowski J; Jeka S; Jodłowska-Cicio K; Kwaśny-Krochin B; Leszczyński P; Lubiński Ł; Łosińska K; Pawlak-Buś K; Przepiera-Będzak H; Samborski W; Schlabs M; Siedlar M; Sikorska D; Świerkot J; Węgierska M; Wiland P; Korkosz M
Reumatologia; 2017; 55(2):59-64. PubMed ID: 28539676
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of Digital PCR Assays for Circulating Tumor DNA Analysis in Advanced Breast Cancer.
Hrebien S; O'Leary B; Beaney M; Schiavon G; Fribbens C; Bhambra A; Johnson R; Garcia-Murillas I; Turner N
PLoS One; 2016; 11(10):e0165023. PubMed ID: 27760227
[TBL] [Abstract][Full Text] [Related]
5. A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg.
Festin MP; Bahamondes L; Nguyen TM; Habib N; Thamkhantho M; Singh K; Gosavi A; Bartfai G; Bito T; Bahamondes MV; Kapp N
Hum Reprod; 2016 Mar; 31(3):530-40. PubMed ID: 26830816
[TBL] [Abstract][Full Text] [Related]
6. House Dust Mite Sensitization Is Inversely Associated with Plasma 25-Hydroxyvitamin D3 Levels in Patients with Severe Atopic Dermatitis.
Jang YH; Sim HB; Moon SY; Lee WJ; Lee SJ; Jin M; Kim SH; Kim DW
Ann Dermatol; 2017 Aug; 29(4):400-406. PubMed ID: 28761286
[TBL] [Abstract][Full Text] [Related]
7. Covalent, Non-Covalent, Encapsulated Nanodrug Regulate the Fate of Intra- and Extracellular Trafficking: Impact on Cancer and Normal Cells.
Kim SW; Lee YK; Kim SH; Park JY; Lee DU; Choi J; Hong JH; Kim S; Khang D
Sci Rep; 2017 Jul; 7(1):6454. PubMed ID: 28743942
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-4 receptor-targeted delivery of Bcl-xL siRNA sensitizes tumors to chemotherapy and inhibits tumor growth.
Guruprasath P; Kim J; Gunassekaran GR; Chi L; Kim S; Park RW; Kim SH; Baek MC; Bae SM; Kim SY; Kim DK; Park IK; Kim WJ; Lee B
Biomaterials; 2017 Oct; 142():101-111. PubMed ID: 28732245
[TBL] [Abstract][Full Text] [Related]
9. Treating an infected transcatheter pacemaker system via percutaneous extraction.
Koay A; Khelae S; Wei KK; Muhammad Z; Mohd Ali R; Omar R
HeartRhythm Case Rep; 2016 Jul; 2(4):360-362. PubMed ID: 28491710
[No Abstract] [Full Text] [Related]
10. Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome.
Przepiera-Będzak H; Brzosko M
Acta Dermatovenerol Croat; 2016 Dec; 24(4):305-306. PubMed ID: 28128085
[TBL] [Abstract][Full Text] [Related]
11. Mean hydrography on the continental shelf from 26 repeat glider deployments along Southeastern Australia.
Schaeffer A; Roughan M; Austin T; Everett JD; Griffin D; Hollings B; King E; Mantovanelli A; Milburn S; Pasquer B; Pattiaratchi C; Robertson R; Stanley D; Suthers I; White D
Sci Data; 2016 Aug; 3():160070. PubMed ID: 27575831
[TBL] [Abstract][Full Text] [Related]
12. Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.
Li J; Qin S; Xu J; Xiong J; Wu C; Bai Y; Liu W; Tong J; Liu Y; Xu R; Wang Z; Wang Q; Ouyang X; Yang Y; Ba Y; Liang J; Lin X; Luo D; Zheng R; Wang X; Sun G; Wang L; Zheng L; Guo H; Wu J; Xu N; Yang J; Zhang H; Cheng Y; Wang N; Chen L; Fan Z; Sun P; Yu H
J Clin Oncol; 2016 May; 34(13):1448-54. PubMed ID: 26884585
[TBL] [Abstract][Full Text] [Related]
13. Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma.
Das A; Cheng RR; Hilbert ML; Dixon-Moh YN; Decandio M; Vandergrift WA; Banik NL; Lindhorst SM; Cachia D; Varma AK; Patel SJ; Giglio P
Cancer Growth Metastasis; 2015; 8():51-60. PubMed ID: 26648752
[TBL] [Abstract][Full Text] [Related]
14. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
[TBL] [Abstract][Full Text] [Related]
15. Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer.
Kim KH; Jelovac D; Armstrong DK; Schwartz B; Weil SC; Schweizer C; Alvarez RD
Gynecol Oncol; 2016 Feb; 140(2):210-4. PubMed ID: 26644263
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer.
Narayan V; Mamtani R; Keefe S; Guzzo T; Malkowicz SB; Vaughn DJ
Cancer Res Treat; 2016 Jul; 48(3):1084-91. PubMed ID: 26639198
[TBL] [Abstract][Full Text] [Related]
17. STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network.
Delyon J; Chevret S; Jouary T; Dalac S; Dalle S; Guillot B; Arnault JP; Avril MF; Bedane C; Bens G; Pham-Ledard A; Mansard S; Grange F; Machet L; Meyer N; Legoupil D; Saiag P; Idir Z; Renault V; Deleuze JF; Hindie E; Battistella M; Dumaz N; Mourah S; Lebbe C;
J Invest Dermatol; 2018 Jan; 138(1):58-67. PubMed ID: 28843487
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial.
Guo J; Carvajal RD; Dummer R; Hauschild A; Daud A; Bastian BC; Markovic SN; Queirolo P; Arance A; Berking C; Camargo V; Herchenhorn D; Petrella TM; Schadendorf D; Sharfman W; Testori A; Novick S; Hertle S; Nourry C; Chen Q; Hodi FS
Ann Oncol; 2017 Jun; 28(6):1380-1387. PubMed ID: 28327988
[TBL] [Abstract][Full Text] [Related]
19. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.
Kikuchi Y; Shimada H; Yamasaki F; Yamashita T; Araki K; Horimoto K; Yajima S; Yashiro M; Yokoi K; Cho H; Ehira T; Nakahara K; Yasuda H; Isobe K; Hayashida T; Hatakeyama S; Akakura K; Aoki D; Nomura H; Tada Y; Yoshimatsu Y; Miyachi H; Takebayashi C; Hanamura I; Takahashi H
Int J Clin Oncol; 2024 May; 29(5):512-534. PubMed ID: 38493447
[TBL] [Abstract][Full Text] [Related]
20. Synthesis,
Boateng ST; Roy T; Torrey K; Owunna U; Banang-Mbeumi S; Basnet D; Niedda E; Alexander AD; Hage DE; Atchimnaidu S; Nagalo BM; Aryal D; Findley A; Seeram NP; Efimova T; Sechi M; Hill RA; Ma H; Chamcheu JC; Murru S
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2205042. PubMed ID: 37184042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
